141 related articles for article (PubMed ID: 9151233)
1. In vivo diagnosis of human malignant melanoma with positron emission tomography using specific melanoma-seeking 18F-DOPA analogue.
Mishima Y; Imahori Y; Honda C; Hiratsuka J; Ueda S; Ido T
J Neurooncol; 1997 May; 33(1-2):163-9. PubMed ID: 9151233
[TBL] [Abstract][Full Text] [Related]
2. A unique in vivo assessment of 4-[10B]borono-L-phenylalanine in tumour tissues for boron neutron capture therapy of malignant melanomas using positron emission tomography and 4-borono-2-[18F]fluoro-L-phenylalanine.
Ishiwata K; Shiono M; Kubota K; Yoshino K; Hatazawa J; Ido T; Honda C; Ichihashi M; Mishima Y
Melanoma Res; 1992 Sep; 2(3):171-9. PubMed ID: 1450671
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCT.
Menichetti L; Cionini L; Sauerwein WA; Altieri S; Solin O; Minn H; Salvadori PA
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S351-4. PubMed ID: 19410471
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part I.
Imahori Y; Ueda S; Ohmori Y; Sakae K; Kusuki T; Kobayashi T; Takagaki M; Ono K; Ido T; Fujii R
Clin Cancer Res; 1998 Aug; 4(8):1825-32. PubMed ID: 9717808
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.
Kabalka GW; Smith GT; Dyke JP; Reid WS; Longford CP; Roberts TG; Reddy NK; Buonocore E; Hübner KF
J Nucl Med; 1997 Nov; 38(11):1762-7. PubMed ID: 9374349
[TBL] [Abstract][Full Text] [Related]
6. The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanoma.
Kabalka GW; Nichols TL; Smith GT; Miller LF; Khan MK; Busse PM
J Neurooncol; 2003; 62(1-2):187-95. PubMed ID: 12749713
[TBL] [Abstract][Full Text] [Related]
7. Selective boron accumulation in human ocular melanoma vs surrounding eye components after 10B1-p-boronophenylalanine administration. Prerequisite for clinical trial of neutron-capture therapy.
Wadabayashi N; Honda C; Mishima Y; Ichihashi M
Melanoma Res; 1994 Jun; 4(3):185-90. PubMed ID: 7919964
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part II.
Imahori Y; Ueda S; Ohmori Y; Sakae K; Kusuki T; Kobayashi T; Takagaki M; Ono K; Ido T; Fujii R
Clin Cancer Res; 1998 Aug; 4(8):1833-41. PubMed ID: 9717809
[TBL] [Abstract][Full Text] [Related]
9. Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography.
Nichols TL; Kabalka GW; Miller LF; Khan MK; Smith GT
Med Phys; 2002 Oct; 29(10):2351-8. PubMed ID: 12408309
[TBL] [Abstract][Full Text] [Related]
10. 4-Borono-2-
Ishiwata K
Ann Nucl Med; 2019 Apr; 33(4):223-236. PubMed ID: 30820862
[TBL] [Abstract][Full Text] [Related]
11. Melanogenesis investigation leading to selective melanoma neutron capture therapy and diagnosis.
Mishima Y
J Dermatol; 1994 Nov; 21(11):907-14. PubMed ID: 7852654
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
Wang HE; Liao AH; Deng WP; Chang PF; Chen JC; Chen FD; Liu RS; Lee JS; Hwang JJ
J Nucl Med; 2004 Feb; 45(2):302-8. PubMed ID: 14960653
[TBL] [Abstract][Full Text] [Related]
13. Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma.
Imahori Y; Ueda S; Ohmori Y; Kusuki T; Ono K; Fujii R; Ido T
J Nucl Med; 1998 Feb; 39(2):325-33. PubMed ID: 9476945
[TBL] [Abstract][Full Text] [Related]
14. Dynamic changes in
Morita T; Kurihara H; Hiroi K; Honda N; Igaki H; Hatazawa J; Arai Y; Itami J
Radiat Oncol; 2018 Jan; 13(1):4. PubMed ID: 29325590
[TBL] [Abstract][Full Text] [Related]
15. In situ detection of cutaneous melanoma by prompt gamma-ray spectrometry using melanoma-seeking 10B-dopa analogue.
Honda C; Mishima Y; Ichihashi M; Hatta S
J Dermatol Sci; 1990 Jan; 1(1):23-31. PubMed ID: 2078538
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and therapeutic indicator of fluoroboronophenylalanine positron emission tomography in patients with gliomas.
Takahashi Y; Imahori Y; Mineura K
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5888-95. PubMed ID: 14676111
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and radiation dosimetry of 4-borono-2-[18F]fluoro-D,L-phenylalanine: a target compound for PET and boron neutron capture therapy.
Ishiwata K; Ido T; Mejia AA; Ichihashi M; Mishima Y
Int J Rad Appl Instrum A; 1991; 42(4):325-8. PubMed ID: 1850716
[TBL] [Abstract][Full Text] [Related]
18. 4-Borono-2-[18F]fluoro-D,L-phenylalanine: a possible tracer for melanoma diagnosis with PET.
Ishiwata K; Ido T; Honda C; Kawamura M; Ichihashi M; Mishima Y
Int J Rad Appl Instrum B; 1992 Apr; 19(3):311-8. PubMed ID: 1629021
[TBL] [Abstract][Full Text] [Related]
19. Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors.
Barth RF; Grecula JC; Yang W; Rotaru JH; Nawrocky M; Gupta N; Albertson BJ; Ferketich AK; Moeschberger ML; Coderre JA; Rofstad EK
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):267-77. PubMed ID: 14697448
[TBL] [Abstract][Full Text] [Related]
20. [Neutron capture therapy for cancer].
Fukuda H; Ichihashi M; Mishima Y
Gan To Kagaku Ryoho; 1994 Feb; 21(3):374-8. PubMed ID: 8109994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
